Morning Briefing
Summaries of health policy coverage from major news organizations
GSK To Offer Flexible Drug Pricing In Middle-Income Countries
Drug maker GlaxoSmithKline (GSK) "plans to bolster earnings by selling to more people in middle-income countries after cutting prices in the world's poorest nations," Bloomberg/BusinessWeek reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
